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Gender differences in daily ambulatory activity
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Objectives: To compare the pattern of daily ambulatory activity in men and women with intermittent claudication, and to
determine whether calf muscle hemoglobin oxygen saturation (StO2) is associated with daily ambulatory activity.
Methods: Forty men and 41 women with peripheral arterial disease limited by intermittent claudication were assessed on
their community-based ambulatory activity patterns for 1 week with an ankle-mounted step activity monitor and on calf
muscle StO2 during a treadmill test.
Results:Women had lower adjusted daily maximal cadence (mean SE) for 5 continuous minutes of ambulation (26.2
1.2 strides/min vs 31.0 1.2 strides/min; P .009), for 1 minute of ambulation (43.1 0.9 strides/min vs 47.2 0.9
strides/min; P  .004), and for intermittent ambulation determined by the peak activity index (26.3  1.2 strides/min
vs 31.0 1.2 strides/min; P .009). Women also had lower adjusted time to minimum calf muscle StO2 during exercise
(P .048), which was positively associated with maximal cadence for 5 continuous minutes (r 0.51; P< .01), maximal
cadence for 1 minute (r  0.42; P < .05), and peak activity index (r  0.44; P < .05). These associations were not
significant in men.
Conclusion:Women with intermittent claudication ambulate slower in the community setting than men, particularly for
short continuous durations of up to 5 minutes and during intermittent ambulation at peak cadences. Furthermore, the
daily ambulatory cadences of women are correlated with their calf muscle StO2 during exercise, as women who walk
slower in the community setting reach their minimum calf muscle StO2 sooner than those who walk at faster paces.
Women with intermittent claudication should be encouraged to not only walk more on a daily basis, but to do so at a pace
that is faster than their preferred speed. (J Vasc Surg 2010;52:1204-10.)Intermittent claudication is a symptom of peripheral
arterial disease (PAD) and is associated with elevated rates
of mortality1-4 and morbidity.5 Intermittent claudication
afflicts 5% of the US population older than 55 years of age6
and occurs during ambulation when the peripheral circula-
tion is inadequate tomeet themetabolic requirement of the
active leg musculature. Thus, intermittent claudication im-
pairs ambulation7,8 and reduces daily physical activity.9
Daily physical activity is lower in patients limited by
intermittent claudication than in age-matched controls9,10
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1204and is associated with mortality risk,11,12 6-minute walk
distance,13 physical function,14 and peak walking time
(PWT), defined as the time at which ambulation cannot
continue due to maximal pain during a standardized tread-
mill test.13,15 In particular, the ambulatory cadence (ie,
stride rate) of daily activities is more closely related to PWT
than the total number of ambulatory strides or the number
of minutes spent ambulating each day,15 suggesting that
intensity of daily ambulation is dependent upon severity
of intermittent claudication. Therefore, factors that influ-
ence intermittent claudication may be key measures in
accounting for differences in ambulatory cadence in pa-
tients with PAD.
We have previously shown that women with intermit-
tent claudication have lower daily physical activity than
men, even though their ankle-brachial index (ABI) is sim-
ilar.16 It is unclear whether the activity level of women is
lower in a community-based setting because of spending
less time in physical activity, because of engaging in less
intense physical activity, or a combination of both. Further,
women have shorter PWT during standardized treadmill
exercise16 and greater calf muscle ischemia during treadmill
exercise than men, measured by hemoglobin oxygen satu-
ration (StO2).
17 These findings suggest that the greater
ambulatory impairment in women becomes even more
pronounced at relatively higher exercise intensities. Calf
muscle StO2 explained differences in PWT between men
and women during treadmill exercise,17 but the association
between calf muscle StO2 and daily ambulatory activity in
men and women has not been evaluated.
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pattern of daily ambulatory activity inmen and womenwith
intermittent claudication by evaluating both the cadence
and time spent ambulating throughout the day, and (2) to
determine whether calf muscle StO2 is associated with daily
ambulatory cadence and time. The hypotheses are that
women have lower daily ambulatory cadences thanmen do,
and that calf muscle StO2 is directly associated with ambu-
latory cadences obtained during community-based ambu-
latory monitoring for 1 week.
METHODS
Subjects
Recruitment. Patients participated in this study at the
General Clinical Research Center (GCRC), at the Univer-
sity of Oklahoma Health Sciences Center (HSC). Patients
were recruited by referrals from the HSC vascular clinic, as
well as by newspaper advertisements. The procedures used
in this study were approved by the Institutional Review
Board at the University of Oklahoma HSC. Written in-
formed consent was obtained from each patient prior to
investigation.
Screening. Patients with intermittent claudication sec-
ondary to vascular insufficiency were included in this study
if they met the following criteria: (1) a history of any type of
exertional leg pain, (2) ambulation during a graded tread-
mill test limited by leg pain consistent with intermittent
claudication,7 and (3) an ABI 0.90 at rest18 or an ABI
0.73 after exercise because some PAD patients have normal
values at rest, which only become abnormal following an
exercise test.19 Patients were excluded from this study for
the following conditions: (1) absence of PAD (ABI 0.90
at rest and ABI 0.73 after exercise), (2) inability to obtain
an ABImeasure due to noncompressible vessels, (3) asymp-
tomatic PAD determined from the medical history and
verified during the graded treadmill test, (4) use of medi-
cations indicated for the treatment of intermittent claudi-
cation (cilostazol and pentoxifylline) initiated within 3
months prior to investigation, (5) exercise tolerance limited
by factors other than leg pain (eg, severe coronary artery
disease, dyspnea, poorly controlled blood pressure), (6)
active cancer, renal disease, or liver disease, (7) calf skinfold
50 mm because of potential interference with the light
path of the near infrared spectrometer (NIRS) probe from
penetrating the subcutaneous tissue, and (8) pulse arterial
oxygen saturation of the index finger 95% because of the
potential deleterious effect on calf muscle StO2 from poor
pulmonary gas exchange.
Measurements
Medical history, physical examination, and anthro-
pometry. Patients arrived at the GCRC in the morning
fasted but were permitted to take their usual morning
medication regimen. Demographic information, height,
weight, cardiovascular risk factors, comorbid conditions,
claudication history, blood samples, and a list of current
medications were obtained from a medical history andphysical examination at the beginning of the study. During
the physical examination, arterial oxygen saturation was
measured from the index finger using a standard pulse
oximeter. Afterwards, subcutaneous fat over the medial
gastrocnemius muscle was measured from a skinfold using a
Lange skinfold caliper according to standard guidelines,20
and waist circumference was recorded using a plastic mea-
suring tape.20
Walking impairment questionnaire (WIQ). Self-
reported ambulatory ability was assessed using a validated
questionnaire for PAD patients that assesses ability to walk
at various speeds and distances and to climb stairs.21
Gardner treadmill test.
Claudication times and peak oxygen uptake. Patients
performed a progressive, graded treadmill protocol to de-
termine study eligibility, as well as to obtain outcome
measures related to peak exercise performance.7 The clau-
dication onset time (COT), defined as the walking time at
which the patient first experienced pain, and the PWT,
defined as the time at which ambulation could not continue
due to maximal pain, were both recorded to quantify the
severity of claudication. Peak oxygen uptake was measured
by oxygen uptake obtained during the peak exercise work-
load with a Medical Graphics VO2000 metabolic system
(Medical Graphics Inc, St. Paul, Minn). Using these pro-
cedures, the test-retest intraclass reliability coefficient is
R 0.89 for COT,7 R 0.93 for PWT,7 and R 0.88 for
peak oxygen uptake.22
ABI and ischemic window. As previously described,
ABI measures were obtained from the more severely dis-
eased lower extremity before and 1, 3, 5, and 7 minutes
after the treadmill test.7,23 The reduction in ankle systolic
blood pressure after treadmill exercise from the resting
baseline value was quantified by calculating the area
under the curve, referred to as the ischemic window.24
Because the ischemic window is a function of both PAD
severity and the amount of exercise performed, the isch-
emic window was normalized per meter walked.
StO2 of the calf musculature. Calf muscle StO2 was
measured before, during, and after exercise using a contin-
uous-wave, NIRS spectrometer (InSpectra model 325;
Hutchinson Technology, Inc, Hutchinson, Minn), an op-
tical cable attached to a 25-mm probe, InSpectra software
(version 2.0), and a dedicated laptop computer as previ-
ously described.25 The probe was attached to the skin over
the medial gastrocnemius muscle of the more severely
affected leg using a double-sided adhesive light-excluding
patch.26 A baseline measure of calf muscle StO2 was ob-
tained at rest as patients stood on the treadmill for 2
minutes to allow for equilibration. From the start of tread-
mill exercise, the minimum StO2 value and the time taken
to reach the minimum value were obtained.
Six-minute walk test. Patients performed an over-
ground, 6-minute walk test supervised by trained exercise
technicians.27 The pain-free and total distance walked dur-
ing the test was recorded. The test-retest intraclass reliabil-
ity coefficient is R 0.75 for distance to onset of claudica-
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distance.27
Ambulatory activity monitoring.
Instrumentation and procedures. Daily ambulatory
activity was assessed using a step activity monitor (Step
Watch 3; Cyma Inc., Mountlake Terrace, Wash) as previ-
ously described.10 Ambulatory activity was measured dur-
ing 7 consecutive days in which patients were instructed to
wear the monitor during waking hours and to remove it
before retiring to bed. The step activity monitor was at-
tached to the right ankle above the lateral malleolus using
elastic Velcro straps and continuously recorded the number
of steps taken on a minute-to-minute basis. The accuracy of
the step activity monitor exceeds 99% 1% in patients with
intermittent claudication.10
Variables obtained from the step activity moni-
tor. The step activity monitor records the number of am-
bulatory strides taken per minute for each minute through-
out a 24-hour period. After data from the step activity
monitor are downloaded to a computer, the software pro-
gram displays the number of strides taken each day and the
number of minutes spent ambulating each day. The daily
ambulatory strides and time are further analyzed by the
software program and are quantified into the following
variables: maximum cadence for 60, 30, 20, and 5 contin-
uous minutes of ambulation each day, maximum cadence
for 1 minute of ambulation each day (ie, the minute having
the single highest cadence value each day), and peak activity
index obtained by ranking all minutes of the day according
to cadence, and then taking the highest 30 values. These
outcome measures are recorded and averaged for each day,
and then the daily averages are averaged over the 7-day
monitoring period. In subjects with intermittent claudica-
tion, the test-retest intraclass reliability coefficient for the
measurement of total daily strides and total daily minutes of
activity over the 7-day period are R  0.87 and R  0.85,
respectively.10 The intraclass reliability coefficients for the
remaining variables pertaining to daily ambulatory ca-
dences range from R  0.83 to R  0.94.10
Statistical analyses
As an initial examination of clinical characteristics of
men and women, differences in means of measurement
variables in men and women were examined using the
independent samples t test and group differences for di-
chotomous variables were examined with 2 procedures.
Since this examination yielded a significant difference in
means for abdominal obesity, the comparisons between
gender of means for ambulatory activity and exercise per-
formance variables were done using analysis of covariance
(ANCOVA) with abdominal obesity as a covariate. To
minimize the possible distorting effect of extreme values,
both Pearson and Spearman partial correlation coefficients
were computed within each gender for each pair of vari-
ables of interest, with Spearman reported only if the two
estimates differed by more than 0.1. All analyses were
performed using the NCSS statistical package. Statisticalsignificance was set at P .05.Measurements are presented
as means  standard deviations.
RESULTS
The clinical characteristics of the men and women with
intermittent claudication are shown in Table I. The groups
were similar on all variables (P  .05), except that women
had a higher prevalence of abdominal obesity (P  .003).
Exercise performance measures of the men and women
adjusted for abdominal obesity are shown in Table II.
Women had lower values for PWT (P .025), peak oxygen
uptake (P .001), calf muscle StO2 at rest (P .010), time
to minimum StO2 during exercise (P  .048), 6-minute
walk pain-free (P  .040) and total walking distance (P 
.001), WIQ speed score (P  .002), and WIQ stair climb-
ing score (P  .001).
Ambulatory activity measures of the men and women
recorded during a 7-day monitoring period and adjusted
for abdominal obesity are shown in Table III. Men and
women had similar daily values for total strides (P  .05)
and total activity time (P  .05). However, women had a
lower daily average cadence (P  .022), a lower peak
activity index (P  .009), and lower maximal cadences for
5 continuous minutes of ambulation (P  .009) and for 1
minute of ambulation (P  .004).
The partial correlation coefficients between the time to
minimum calf muscle StO2 during treadmill exercise and
the ambulatory activity measures of the men and women
are shown in Table IV. In women, after adjusting for
covariates, the time to minimum calf muscle StO2 was
positively associated with peak activity index (P .05) and
with daily maximal cadences for continuous durations of 20
minutes (P  0.05), 5 minutes (P  .01), and 1 minute
(P  .05). In contrast, the time to minimum calf muscle
StO2 was not significantly correlated with any of the ambu-
Table I. Clinical characteristics of men and women with
intermittent claudication
Variables
Men
(n  40)
Women
(n  41) P value
Age (years) 66.3 (10.0) 64.1 (10.9) .350
Weight (kg) 87.7 (20.3) 79.9 (19.4) .085
Body mass index (kg/m2) 28.3 (6.1) 30.3 (6.8) .183
Ankle-brachial index 0.75 (0.23) 0.68 (0.27) .241
Race (% Caucasian) 58 37 .059
Current smoking (% yes) 35 51 .175
Diabetes (% yes) 43 51 .432
Hypertension (% yes) 88 83 .562
Dyslipidemia (% yes) 88 95 .222
Abdominal obesity (% yes) 35 68 .003
Metabolic syndrome (% yes) 78 80 .741
Obesity (% yes) 35 51 .141
Values are means (standard deviation) or percentage of subjects in each
category.latory activity measures in men.
aire.
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This investigation extends our previous finding that
daily physical activity levels of women with intermittent
claudication are lower than men16 by demonstrating that
this is primarily due to lower ambulatory cadences rather
than spending less time in physical activity. Another new
finding of this study was that daily ambulatory cadences
were directly correlated with calf muscle StO2 measure-
ments in women but not in men.
Differences in daily ambulatory cadence between
men and women. One novel aspect to this investigation
was to compare the pattern of daily ambulatory activity
between men and women in a community-based setting,
rather than to simply examine the total activity level. We
found that women ambulate at slower cadences than men
do for relatively short durations of 1 and 5 minutes, and
that their average daily cadence is 13% slower as well. In
addition to ambulating more slowly during continuous
ambulatory periods of up to 5 minutes, women also ambu-
late 15% slower on an intermittent basis. The slower inter-
mittent ambulation is reflected by the peak activity index,
which is the average cadence of the 30 minutes having the
highest cadence values throughout the day. In contrast to
Table II. Exercise measures of men and women with inte
Variables
Claudication onset time (s)
Peak walking time (s)
Peak oxygen uptake (mL · kg1 · min1) 1
Ischemic window (mm Hg  min/m) 0
StO2 at rest (% saturation)
Minimum StO2 (% saturation)
Time to minimum StO2 (s)
6-minute walk pain-free distance (meters)
6-minute walk distance (meters)
WIQ distance score (%)
WIQ speed score (%)
WIQ stair climbing score (%)
StO2, Hemoglobin oxygen saturation; WIQ, walking impairment questionn
Values are means (SE) adjusted for abdominal obesity.
Table III. Ambulatory activity of men and women with in
period
Variables
Total strides (strides/d)
Total activity time (min/d)
Maximum 1-minute cadence (strides/min)
Maximum 5-minute cadence (strides/min)
Maximum 20-minute cadence (strides/min)
Maximum 30-minute cadence (strides/min)
Maximum 60-minute cadence (strides/min)
Peak activity index (strides/min)
Average cadence (strides/min)
Values are means (SE) adjusted for abdominal obesity.ambulatory cadence, which represents the intensity of dailyambulation, the women spent a similar amount of time in
daily ambulation as men, and the total number of daily
strides was similar as well. Thus, the primary gender-related
difference in daily ambulatory patterns of patients with
intermittent claudication is that women ambulate at slower
cadences.
The current study may explain why we previously
found an 18% lower total daily activity level in women
than in men as measured by an accelerometer.16 An
accelerometer worn at the waist measures vertical accel-
erations during both ambulatory and nonambulatory
movements. Our current finding that women are similar
to men on both daily strides and daily ambulatory time,
suggests that the lower total daily energy expenditure of
women found in our previous study may be due to lower
accelerations generated during slower ambulation. Fur-
thermore, although the total number of strides taken
each day was similar between men and women, the
women ambulated at a slower cadence for continuous
durations of up to 5 minutes and for intermittent walk-
ing. Our previous finding of objectively measured lower
total daily activity16 and our current finding of slower
ambulation in women supports earlier work that women
ent claudication
en
40)
Women
(n  41) P value
27) 182 (26) .181
44) 360 (43) .025
0.5) 10.9 (0.5) .001
0.11) 0.64 (0.11) .569
3) 48 (3) .010
3) 15 (3) .429
40) 187 (39) .048
18) 147 (17) .040
14) 297 (13) .001
5) 32 (5) .104
3) 26 (3) .002
4) 30 (4) .001
ittent claudication recorded during a 7-day monitoring
Men
 40)
Women
(n  41) P value
4 (265) 3372 (268) .571
2 (16) 290 (16) .114
2 (0.9) 43.1 (0.9) .004
0 (1.2) 26.2 (1.2) .009
9 (1.2) 15.7 (1.2) .068
9 (1.0) 13.2 (1.0) .086
5 (0.8) 9.9 (0.8) .175
0 (1.2) 26.3 (1.2) .009
5 (0.5) 10.9 (0.5) .022rmitt
M
(n 
236 (
509 (
4.4 (
.55 (
59 (
19 (
305 (
202 (
379 (
44 (
41 (
53 (term
(n
314
25
47.
31.
18.
15.
11.
31.
12.with PAD self-report leaving their house and neighbor-
JOURNAL OF VASCULAR SURGERY
November 20101208 Gardner et alhood less frequently, walking fewer blocks, and sweating
less often than women without PAD.28
Differences in calf muscle StO2 during exercise in
men and women. The most important characteristic of
calf muscle StO2 during exercise in patients with intermit-
tent claudication is the observed time to reach the mini-
mum StO2 value, as this measure is positively associated
with COT and PWT, and negatively associated with isch-
emic window in patients with intermittent claudica-
tion.17,25 The current study supports our previous findings
that women have shorter time to minimum calf muscle
StO2 and PWT during treadmill exercise.
17 The shorter
time to reach minimum calf muscle StO2 in women sug-
gests that they have greater impairment in the increase in
capillary blood volume during exercise.29 This notion of
greater microcirculatory impairment in women with inter-
mittent claudication is supported from recent work in our
laboratory showing that small artery elasticity index is 18%
lower in women.30
The novel aspect to this finding is that the time to
minimum calf muscle StO2 was significantly correlated with
daily ambulatory cadence in women, but not in men. The
more rapid oxygen desaturation in the calf muscle of
women during exercise suggests that more ambulatory
activity in the community setting is performed while expe-
riencing calf ischemia than compared with men walking at
any given intensity. Women may decrease their ambulatory
cadence because they experience painful ambulation more
frequently or, alternatively, they may select slower ambula-
tory paces while walking in the community setting as a
strategy to avoid experiencing the onset of claudication.
Walking slowly due to the onset of claudication is more
likely to occur with longer activity durations, as measured
Table IV. Ambulatory activity measures recorded during
a 7-day monitoring period and their associations with the
time to minimum calf muscle hemoglobin saturation
(StO2) during treadmill exercise
Variables
Time
to minimum
StO2 in 40
men (r)
Time
to minimum
StO2 in 41
women (r)
Maximum 1-minute cadence 0.10 0.42a
Maximum 5-minute cadence 0.08 0.51b
Maximum 20-minute cadence 0.01 0.38a
Maximum 30-minute cadence 0.01 0.36
Maximum 60-minute cadence 0.02 0.28
Peak activity index 0.03 0.44a
Average cadence 0.03 0.30
Total strides 0.23 0.18
Total activity time 0.20 0.15
r  Pearson partial correlation coefficients or Spearman partial correlation
coefficients (indicated in italicized print), adjusting for age, obesity, ankle-
brachial index, current smoking, abdominal obesity, dyslipidemia, diabetes,
hypertension, and metabolic syndrome.
aP  .05.
bP  .01.by themaximum 5-minute cadence, whereas the strategy ofambulating slowly to avoid experiencing claudication is
more likely to be evident for short activity duration, as
measured by the maximum 1-minute cadence or for inter-
mittent ambulation, as measured by the peak activity index.
Although the calf muscle StO2 is a significant factor
influencing daily ambulatory cadences in women, factors
other than calf muscle StO2 may be associated with daily
ambulatory cadences in men. These may include factors that
correlate with PWT during a standardized treadmill test, such
as cardiopulmonary function,31 walking economy,32 muscle
mass,33 muscle strength,34 obesity,35 metabolic syn-
drome,36 and current smoking.37 The reasons for why calf
muscle StO2 is more strongly associated with daily ambu-
latory cadences in women require further investigation
beyond the scope of this study.
Study limitations. There are limitations to this study
that are associated with the measurement of calf muscle
StO2 as previously described.
25 Briefly, myoglobin may
partially contribute to the calf muscle StO2 measurement,
capillary and venular blood have different oxygen satura-
tions and may mix in the local tissue, and the subcutaneous
fat thickness directly under the probemay interfere with the
measure of calf muscle StO2. However, we believe these
limitations have minimal influence on calf muscle StO2 as
discussed earlier.25 Another limitation is related to the
comparison of calf muscle StO2 between men and women.
On average, men are taller than women are and have longer
stride lengths. Thus, walking at a given speed during the
treadmill test requires shorter subjects to take more strides,
which may partially explain the shorter time to minimum
calf muscle StO2 in the women. However, we did not
believe that adjusting for height was appropriate because
this would essentially control for gender and would over-
adjust the model.
There are limitations associated with the step activity
monitor such as the possibility that patients did not wear
the step activity monitor during portions of their waking
hours, thereby resulting in an underestimate of daily am-
bulation.15 We believe this possibility is unlikely because
long durations in which no active minutes were recorded
during daytime hours were rarely evident from the software
graphs depicting the number of strides taken on a minute-
to-minute basis. Even during several hours of being seden-
tary, a few minutes in which some strides occur were
typically evident, indicating that the step activity monitor
had not been removed. Another limitation is that the type
of sedentary activity, which takes place during nonactive
minutes, cannot be determined by the step activity moni-
tor. Consequently, it is not possible to quantify the time
spent in various sedentary activities such as watching tele-
vision, reading, taking naps, and sitting while eating. Fur-
thermore, the step activity monitor does not quantify
nonambulatory physical activity, and therefore, it underes-
timates the total amount of daily physical activity to some
extent. Additionally, the types of ambulatory activities can-
not be determined. Thus, it is possible that men were
engaged in activities requiring higher ambulatory cadences,
which may be unrelated to the vascular status of the calf
JOURNAL OF VASCULAR SURGERY
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typically limits the cadence that can be sustained, especially
during prolonged ambulatory bouts. Thus, most PAD
patients are not capable of performing activities requiring
high ambulatory cadences.
Finally, there are limitations associated with the design
of the study. The correlations calculated between daily
ambulatory activity and calf muscle StO2 from this cross-
sectional design do not allow causality to be established, as
it is possible that daily ambulation influences calf muscle
StO2 or vice versa. Furthermore, the results of this study are
only applicable to PAD patients who are limited by inter-
mittent claudication andmay not be generalized to patients
with less severe or more severe PAD. Another potential
weakness to the design of this study was not having ambu-
latory activity data of men and women controls to compare
with the PADpatients.We did not include controls because
we have already found that PAD patients have lower values
on nearly all ambulatory measures,16 and we believed it to
be duplication of effort to include controls in the current
investigation.
CONCLUSION AND CLINICAL IMPLICATION
Women with intermittent claudication ambulate slower
in the community setting than men, particularly for short
continuous durations of up to 5 minutes and during inter-
mittent ambulation at peak cadences. Furthermore, the
daily ambulatory cadences of women are correlated with
their calf muscle StO2 during exercise, as women who walk
slower in the community setting reach their minimum calf
muscle StO2 sooner than those who walk at faster paces.
The clinical significance is that women with intermittent
claudication should be encouraged to not only walk more
on a daily basis, but to do so at a pace that is faster than their
preferred speed.
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